title: Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis.
abstract: OBJECTIVE
  To compare the effectiveness and safety of three types of stents (sirolimus eluting, paclitaxel eluting, and bare metal) in people with and without diabetes mellitus.
  
  
  METHODS
  Collaborative network meta-analysis.
  
  
  METHODS
  Electronic databases (Medline, Embase, the Cochrane Central Register of Controlled Trials), relevant websites, reference lists, conference abstracts, reviews, book chapters, and proceedings of advisory panels for the US Food and Drug Administration. Manufacturers and trialists provided additional data.
  
  
  METHODS
  Network meta-analysis with a mixed treatment comparison method to combine direct within trial comparisons between stents with indirect evidence from other trials while maintaining randomisation. Overall mortality was the primary safety end point, target lesion revascularisation the effectiveness end point.
  
  
  RESULTS
  35 trials in 3852 people with diabetes and 10,947 people without diabetes contributed to the analyses. Inconsistency of the network was substantial for overall mortality in people with diabetes and seemed to be related to the duration of dual antiplatelet therapy (P value for interaction 0.02). Restricting the analysis to trials with a duration of dual antiplatelet therapy of six months or more, inconsistency was reduced considerably and hazard ratios for overall mortality were near one for all comparisons in people with diabetes: sirolimus eluting stents compared with bare metal stents 0.88 (95% credibility interval 0.55 to 1.30), paclitaxel eluting stents compared with bare metal stents 0.91 (0.60 to 1.38), and sirolimus eluting stents compared with paclitaxel eluting stents 0.95 (0.63 to 1.43). In people without diabetes, hazard ratios were unaffected by the restriction. Both drug eluting stents were associated with a decrease in revascularisation rates compared with bare metal stents in people both with and without diabetes.
  
  
  CONCLUSIONS
  In trials that specified a duration of dual antiplatelet therapy of six months or more after stent implantation, drug eluting stents seemed safe and effective in people both with and without diabetes.
authors.affiliation: Institute of Social and Preventive Medicine, University of Bern, 3012 Bern, Switzerland.
authors.forename: Christoph
authors.initials: C
authors.lastname: Stettler
authors.forename: Sabin
authors.initials: S
authors.lastname: Allemann
authors.forename: Simon
authors.initials: S
authors.lastname: Wandel
authors.forename: Adnan
authors.initials: A
authors.lastname: Kastrati
authors.forename: Marie Claude
authors.initials: MC
authors.lastname: Morice
authors.forename: Albert
authors.initials: A
authors.lastname: Schömig
authors.forename: Matthias E
authors.initials: ME
authors.lastname: Pfisterer
authors.forename: Gregg W
authors.initials: GW
authors.lastname: Stone
authors.forename: Martin B
authors.initials: MB
authors.lastname: Leon
authors.forename: José Suárez
authors.initials: JS
authors.lastname: de Lezo
authors.forename: Jean-Jacques
authors.initials: JJ
authors.lastname: Goy
authors.forename: Seung-Jung
authors.initials: SJ
authors.lastname: Park
authors.forename: Manel
authors.initials: M
authors.lastname: Sabaté
authors.forename: Maarten J
authors.initials: MJ
authors.lastname: Suttorp
authors.forename: Henning
authors.initials: H
authors.lastname: Kelbaek
authors.forename: Christian
authors.initials: C
authors.lastname: Spaulding
authors.forename: Maurizio
authors.initials: M
authors.lastname: Menichelli
authors.forename: Paul
authors.initials: P
authors.lastname: Vermeersch
authors.forename: Maurits T
authors.initials: MT
authors.lastname: Dirksen
authors.forename: Pavel
authors.initials: P
authors.lastname: Cervinka
authors.forename: Marco
authors.initials: M
authors.lastname: De Carlo
authors.forename: Andrejs
authors.initials: A
authors.lastname: Erglis
authors.forename: Tania
authors.initials: T
authors.lastname: Chechi
authors.forename: Paolo
authors.initials: P
authors.lastname: Ortolani
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Schalij
authors.forename: Peter
authors.initials: P
authors.lastname: Diem
authors.forename: Bernhard
authors.initials: B
authors.lastname: Meier
authors.forename: Stephan
authors.initials: S
authors.lastname: Windecker
authors.forename: Peter
authors.initials: P
authors.lastname: Jüni